Buy Rating on Valneva Supported by Promising Vaccine Developments and Solid Revenue Projections
TipRanksMar 26 21:25
Valneva Analyst Ratings
BenzingaMar 23 01:57
Guggenheim Maintains Buy on Valneva, Lowers Price Target to $17
BenzingaMar 23 01:59
Valneva Analyst Ratings
BenzingaMar 21 18:40
Buy Rating Affirmed for Valneva: Strong Core Growth and Strategic Financial Health
TipRanksMar 21 18:16
HC Wainwright & Co. Reiterates Buy on Valneva, Maintains $26 Price Target
BenzingaMar 1 04:03
Valneva Analyst Ratings
BenzingaMar 1 04:02
Buy Rating Affirmed for Valneva on Strong Vaccine Market Prospects and Positive Regulatory Developments
TipRanksFeb 29 23:15
HC Wainwright & Co. Reiterates Buy on Valneva, Maintains $26 Price Target
BenzingaFeb 16 01:44
Valneva Analyst Ratings
BenzingaFeb 16 01:42
Analysts Are Bullish on These Healthcare Stocks: Valneva (VALN), Aurinia Pharmaceuticals (AUPH)
TipRanksFeb 16 01:20
Valneva's Promising Financial Future Bolstered by Vaccine Developments and Strategic Sales: A Buy Rating Analysis
TipRanksFeb 6 00:35
Buy Rating for Valneva as Ixchiq Vaccine Shows Market Promise and Progress in Pediatric Trials
TipRanksJan 10 22:05
Positive Outlook for Valneva: A Buy Rating With a $26 Price Target
TipRanksJan 5 23:25
HC Wainwright & Co. Reiterates Buy on Valneva, Maintains $26 Price Target
BenzingaDec 5, 2023 01:42
Valneva Analyst Ratings
BenzingaDec 5, 2023 01:40
Buy Rating Justified by Valneva's Promising Vaccine Prospects and Strong Market Potential
TipRanksDec 4, 2023 23:25
Analysts Offer Insights on Healthcare Companies: Valneva (VALN) and Roivant Sciences (ROIV)
TipRanksNov 27, 2023 22:10
Valneva Analyst Ratings
BenzingaNov 10, 2023 21:04
Needham Reiterates Buy on Valneva, Maintains $22 Price Target
BenzingaSep 27, 2023 19:01
No Data
No Data